Biotechnology
Our work
Our Biotechnology segment, led by Cytiva, brings dedicated technical expertise and talent to help our customers commercialize the next generation of therapeutics.
Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotechnology, and large-scale biopharmaceutical and contract manufacturers.
Our Cytiva team partners with customers every day to bring innovative therapies to market with less risk, enabling execution from discovery to delivery. We combine our expertise and a broad and deep portfolio to help expand access to life-changing therapies to transform human health.
Chris Riley
Vice President and Group Executive, Biotechnology